Mr. Tasuku Honjo, who won the Nobel Prize in Physiology or Medicine, is asking a pharmaceutical company in Osaka to pay more than 26 billion yen over the patent royalties for cancer treatments involved in the development. On the 2nd, the president of the company went to court with each other and made a head-on conflict.
Mr. Tasuku Honjo, a special professor at Kyoto University who won the Nobel Prize in Physiology or Medicine three years ago, used a patent for Ono Pharmaceutical Co., Ltd. in Osaka, which manufactures and sells Opdivo, a cancer treatment drug that he was involved in developing. He has filed a lawsuit demanding payment of 26.2 billion yen, claiming that the distribution of fees is abnormally low.
At the trial held at the Osaka District Court on the 2nd, Mr. Honjo and President Gyo Sagara of Ono Pharmaceutical Co., Ltd. were cross-examined.
And they both argued that Ono Pharmaceutical paid 1% of the amount obtained from the settlement to Mr. Honjo, who cooperated in the settlement of another trial with an American pharmaceutical company over the drug patent. Said.
Mr. Honjo said, "The president had proposed to pay 40% in advance. It is very surprising and impossible to ask for cooperation in the trial but not talk about it later. I complained.
On the other hand, President Sagara admitted that he had made a 40% proposal, and argued that he paid with the allocation based on the previous contract because Mr. Honjo rejected it as "It's a lot of money" and so on. Insisted.